BEST UNLIMITED TURBO LONG CERTIFICATE - GSK PLC Share Price

Certificat

13KUZ

DE000CR9R0A6

Market Closed - Euronext Paris 17:14:58 02/05/2024 BST
1.974 EUR +5.56% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - GSK PLC
Current month+5.56%
1 month+7.11%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart GSK PLC
Chart BEST UNLIMITED TURBO LONG CERTIFICATE - GSK PLC
Date Price Change Volume
02/05/24 1.974 +5.56% 98
30/04/24 1.87 +1.63% 90
29/04/24 1.84 +1.15% 93
26/04/24 1.819 +1.85% 91
25/04/24 1.786 +1.25% 89

Real-time Euronext Paris

Last update May 02, 2024 at 05:14 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying GSK PLC
IssuerLogo Issuer Société Générale Société Générale
13KUZ
ISINDE000CR9R0A6
Date issued 29/07/2015
Strike 884.3 p
Maturity Unlimited
Parity 5 : 1
Emission price 0.43
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.432
Lowest since issue 0.695

Company Profile

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed monoclonal antibodies to help treat different diseases. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes more than 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines include medicines for immune-mediated conditions. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases.
Sector
-
More about the company

Ratings for GSK plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: GSK plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
17.05 GBP
Average target price
20.2 GBP
Spread / Average Target
+18.45%
Consensus
  1. Stock Market
  2. Certificates
  3. 13KUZ Certificat